IDO1 and ovarian cancer: Likewise, LW-106 demonstrated a potent antitumor activity based on a similar mechanism in the IDO-overexpressing melanoma mouse model, while NTRC 3883-0 in ovarian cancer cell culture and melanoma mouse model (Table 1) [94,95].